Childrens Hospital Kings Daughter - Homepage

  • Gene therapy - Proud and Blanchard - CHKD

    Duchenne Treatment Expanded

    A groundbreaking gene therapy for Duchenne muscular dystrophy has been expanded by the FDA for children ages 4 and up. CHKD’s Chief of Neurology Dr. Crystal Proud, one of the world’s leading researchers on this treatment, is excited to offer it to more patients. 

    Read More
  • spine program hp size

    Spine Program Success

    CHKD’s Spine Program is the first in the nation to be awarded DNV Advanced Pediatric Spine Certification! This certification designates that our facilities and services meet the standards of care in the complex specialty of spine surgery. Way to go, team!

    Read More
  • Dr. Glenda Karp with Patients at Tidewater Children's Associates

    Our Docs Are Tops

    Many CHKD pediatricians, surgeons, and specialists were chosen by their peers as being the best in their field and were named 2024 Top Docs by Virginia Business magazine. Read more to see who made this year's list.

    Read More
  • pharmacy ribbon cutting

    Pharmacy Now Open

    CHKD's new outpatient pharmacy offers retail and specialty pharmacy services as well as counseling to patients, families, and staff about the safe, effective use of medicines. Prescription refills, with easy online ordering will also be available.  

    Read More

Chair of Pediatrics Selected

Dr. Eric Lowe, Medical Director of Pediatric Oncology, has been selected as Chief Clinical Academic Officer at CHKD and chair of the Department of Pediatrics at EVMS, part of Macon & Joan Brock Virginia Health Sciences at Old Dominion University. His appointment will be effective September 1, 2024.

Read More

Free Home Delivery

In a continuous effort to support the health and well-being of our community, CHKD Outpatient Pharmacy now offers FREE home delivery! Questions about home delivery? Please call the outpatient pharmacy at (757) 668-6337.

Read More

New Cancer Treatment

CHKD now offers CAR-T cell therapy, a breakthrough treatment for children with certain types of cancer.  Read more about how CAR-T cell therapy is helping patients, up to age 25, with B cell acute lymphoblastic leukemia (ALL) whose cancer did not respond to chemotherapy or whose leukemia has come back.

There are no alerts at this time.